1. The 2,4-pyrimidinediamine compound for use in the treatment of autoimmune diseases other than ulcerative colitis, Crohn's disease, inflammatory bowel disease and idiopathic inflammatory bowel disease, where the 2,4-pyrimidinediamine compound is: a compound of structural formula (I): or its salt, hydrate, solvate and / or N-oxide, where: L1 and L2 are each a direct bond； R2 is selected from the group consisting of the following: phenyl mono substituted at the 3- or 5-position with the help of the group R8, phenyl di or tri-substituted by one or several with identical or different groups of R8 and optionally substituted heteroaryl as defined below； R4 is selected from the group consisting of the following: phenyl substituted with one or more identical or different R 8 groups and optionally substituted heteroaryl as defined below； characterized in that for R2 and R4, each of these optionally substituted heteroaryls, independently of one another, are selected from the group consisting of: where p is an integer from one to three； each independently represents a single bond or double th bond； R35 is hydrogen or R8； X is selected from the group consisting of CH, N and NO； each Y is independently selected from the group consisting of O, S and NH； each Y1 is independently selected from the group consisting of O, S, SO, SO2, SONR36, NH, and NR37； each Y2 is independently selected from the group consisting of CH, CH2, O, S, N, NH, and NR37； R36 is hydrogen or alkyl； R37 is selected from the group consisting of hydrogen and progroup, selected from the group consisting of the following: aryl, arylalkyl, heteroaryl, R, R, -CRR-OC (O) R, -CRR-O-PO (OR), -CH-O-PO (OR), -CH- PO (OR), -C (O) -CRR-N (CH), -CRR-OC (O) -CRR-N (CH), -C (O) R, -C (O) CF and -C (O ) -NR-C (O) R； R38 is selected from the group consisting of alkyl1. Соединение 2,4-пиримидиндиамина для применения в лечении аутоиммунных заболеваний, отличных от язвенного колита, болезни Крона, воспалительная болезнь кишечни
